‘Proteolytic switching’: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
1999
Regulation of Gelatinase B and TIMP-1 in Melanoma Progression
publication
Author Information
Author(s): MacDougall J R, Bani M R, Lin Y, Muschel R J, Kerbel R S
Primary Institution: Cancer Biology Research, Sunnybrook Health Science Centre
Hypothesis
How do gelatinase B and its inhibitor TIMP-1 regulate during human melanoma progression?
Conclusion
The study found that the regulation of gelatinase B and TIMP-1 changes during melanoma progression, affecting the disease's aggressiveness.
Supporting Evidence
- The advanced melanoma cell line could produce gelatinase B when induced, while the early stage cell line could not.
- The early stage cell line showed increased production of TIMP-1 when treated with certain cytokines, unlike the advanced cell line.
- Overexpression of gelatinase B enhanced lung colonization in experimental assays.
Takeaway
This study shows that as melanoma progresses, the way certain proteins behave changes, which can make the cancer more aggressive.
Methodology
The study analyzed two genetically related human melanoma cell lines from the same patient at different disease stages to assess the regulation of gelatinase B and TIMP-1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website